VAN ECK ASSOCIATES CORP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7
-30.0%
2,337
+18.9%
0.00%
Q2 2023$10
-9.1%
1,966
-11.0%
0.00%
Q1 2023$11
-31.2%
2,208
-12.8%
0.00%
Q4 2022$16
-99.9%
2,531
+37.7%
0.00%
Q3 2022$20,0001,8380.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders